ARCHIVES

DCE Board Approves Concepts For New Chemoprevention Groups, Retroviral Vaccine Research, Biochemical Markers, Feline Virus Studies

This article is from The Cancer Letter archive.

Vol. 11 No. 11 | March 15, 1985

Download PDF Visit The Full Archive

Related Articles

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

NIH Signs Agreement For Use Of Five Stem Cell Lines.

September 7, 2001

NCI Test Panels Available For Marker Evaluation

March 2, 1984

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

April 26, 2002

Study: BRCA2-Negative Women Could Still Have High Risk

December 27, 2013

UCLA, NYU, Ohio States Must Wait Longer For Comprehensive Status

November 28, 1975